New flavones with antidiabetic activity from Callistemon lanceolatus DC

Area of Science:

• Phytochemistry
• Pharmacology
• Natural Products Chemistry

Background:

• Callistemon lanceolatus (Myrtaceae) is a plant species with traditional medicinal uses.
• Flavonoids are a class of plant secondary metabolites known for diverse biological activities.
• Diabetes mellitus remains a significant global health challenge requiring novel therapeutic strategies.

Purpose of the Study:

• To isolate and characterize novel phytochemicals from the aerial parts of Callistemon lanceolatus.
• To evaluate the potential hypoglycemic activity of the isolated compounds.
• To contribute to the understanding of the chemical constituents of Callistemon lanceolatus and their pharmacological relevance.

Main Methods:

• Phytochemical investigation involving extraction and isolation techniques.
• Structure elucidation of isolated compounds using spectroscopic methods (e.g., NMR, Mass Spectrometry).
• In vivo evaluation of blood glucose-lowering effects in streptozotocin-induced diabetic rat models.

Main Results:

• Isolation of two new flavones: 5,7-dihydroxy-6,8-dimethyl-4'-methoxy flavone (1) and 8-(2-hydroxypropan-2-yl)-5-hydroxy-7-methoxy-6-methyl-4'-methoxy flavone (2).
• Identification of seven known phytoconstituents.
• Demonstration of significant blood glucose lowering activity by the isolated flavones in diabetic rats.

Conclusions:

• The study successfully identified novel flavone derivatives from Callistemon lanceolatus.
• The isolated flavones possess notable hypoglycemic properties, suggesting therapeutic potential for diabetes management.
• Further research into these compounds could lead to the development of new anti-diabetic agents.